DLC MEDICAL LTDActive

Company number 08088416Private limited companyIncorporated 2012

Key figures

£318,467+20.2%
Net assets 2024/25
+22.8%
Average annual growth 2020/21–2024/25
0100 k200 k300 k400 k2020/212021/222022/232023/242024/25

Like most small UK companies, DLC MEDICAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2020/212021/222022/232023/242024/25

Dividends

from the accounts
2021/22

Dividends paid in the financial year: £4,000.

History
2021/22£4,000
2020/21£4,000
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand101,973150,369———
Total assets165,307211,410292,854304,966365,487
Total liabilities25,28219,64158,68538,82324,134
Net assets / total equity140,025191,552234,030265,004318,467
Average number of employees22220
Dividends paid4,0004,000———

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DLC MEDICAL LTD

Company

DLC MEDICAL LTD is a private limited company registered with Companies House under company number 08088416. It was incorporated on 30 May 2012. Its status is active. The registered office is in Stockport (SK7). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files micro-entity accounts. Net assets were £318,467, up 20.2% on the previous year. Total assets were £365,487 and total liabilities £24,134. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 13 Jun 2027.